MRK vs NVS: stock comparison and AI forecast
Merck & Co., Inc. (MRK) and Novartis Ag (NVS) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
MRK Merck & Co., Inc.
- Market Cap
- $366.03B
- P/E Ratio
- 118.7x
- Size
- mega-cap
- AI Forecast
NVS Novartis Ag
- Price
- $161.52 +11.7% · 6M
- Market Cap
- $308.20B
- P/E Ratio
- 9.7x
- Size
- mega-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- MRK is 1.2 times larger than NVS by market capitalization ($366.03B against $308.20B).
- NVS trades at 9.7 times trailing earnings, MRK at 118.7 times.
- MRK carries 2.09 times debt per unit of equity, against 1.40 times for NVS.
- MRK yields 2.27% in dividends; NVS pays none.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | MRK | NVS |
|---|---|---|
| Market Cap | $366.03B | $308.20B |
| P/E Ratio | 118.69x | 9.69x |
| P/B Ratio | 8.73x | – |
| Dividend Yield | 2.27% | – |
| EPS | $1.25 | $16.67 |
| Book Value/Share | $17.00 | – |
| Revenue/Share | $26.98 | – |
| FCF/Share | $6.51 | $23.48 |
Profitability & Margins
| Metric | MRK | NVS |
|---|---|---|
| ROE | 7.6% | 72.0% |
| ROA | 2.4% | 29.9% |
| ROIC | – | 49.1% |
| Gross Margin | 73.0% | – |
| Net Margin | 4.8% | – |
| EBT Margin | 8.9% | – |
| Tax Rate | 46.7% | 13.5% |
Financial Health
| Metric | MRK | NVS |
|---|---|---|
| Current Ratio | 1.32x | 1.12x |
| Quick Ratio | 1.10x | 0.89x |
| D/E Ratio | 2.09x | 1.40x |
| Financial Leverage | 3.10x | 2.41x |
| Working Capital | $8.95B | $3.18B |
Cash Flow
| Metric | MRK | NVS |
|---|---|---|
| Operating Cash Flow | $19.97B | $48.30B |
| Free Cash Flow | $16.06B | $44.80B |
| Capital Spending | -$3.90B | -$3.50B |
| OCF Growth YoY | 7.7% | 34.1% |
| FCF Growth YoY | 9.1% | 0.0% |
| FCF/Sales | 24.1% | – |
| CapEx/Sales | 5.9% | – |
Operational Efficiency
| Metric | MRK | NVS |
|---|---|---|
| Asset Turnover | 0.51x | – |
| Receivables Turnover | 5.3x | – |
| Inventory Turnover | 2.9x | 5.3x |
| Fixed Assets Turnover | 2.6x | – |
| Days Sales Outstanding | 69 days | – |
| Days Inventory | 126 days | 69 days |
| Payables Period | 78 days | – |
| Cash Conversion Cycle | 117 days | – |
Income Statement
| Metric | MRK | NVS |
|---|---|---|
| Total Revenue | $66.57B | – |
| Operating Income | – | $41.07B |
| Net Income | $3.17B | $33.21B |
| R&D Expense | $30.45B | $26.32B |
| SG&A Expense | $11.14B | $32.35B |
| Cost of Goods Sold | $18.00B | $33.02B |
Dividend & Shareholder Information
| Metric | MRK | NVS |
|---|---|---|
| Dividends Per Share | $3.36 | – |
| Payout Ratio | 268.8% | – |
| Shares Outstanding | 2467M | 1908M |
| Net Income Growth | -80.7% | 28.6% |
| EPS Growth | -80.8% | 37.2% |
MRK vs NVS: stock comparison and AI forecast
Which is bigger, MRK or NVS?
MRK is 1.2 times larger than NVS by market capitalization ($366.03B against $308.20B).
Which is cheaper on earnings, MRK or NVS?
NVS trades at 9.7 times trailing earnings, MRK at 118.7 times.
Which one does Intratio's AI model rank higher, MRK or NVS?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.